Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25552
Title: Unusual location of recurrent mantle cell lymphoma on fluorodeoxyglucose-positron emission tomography despite complete metabolic resolution of previous sites of disease.
Austin Authors: Froitzheim, Benjamin M W;Boktor, Raef R;Lau, Eddie ;Lee, Sze Ting 
Affiliation: University of Regensburg, Regensburg, Germany
Radiology
Department of Medicine, University of Melbourne, Melbourne, Australia
Molecular Imaging and Therapy
Olivia Newton-John Cancer Research Institute
School of Cancer Medicine, LaTrobe University, Melbourne, Australia
Issue Date: 1-Jul-2020
Date: 2020-07
Publication information: World Journal of Nuclear Medicine 2020; 19(3): 277-280
Abstract: This case report presents a patient with recurrent pleomorphic mantle cell lymphoma (MCL), which is a relatively rare but aggressive type of lymphoma. A positron emission tomography/computed tomography scan performed to assess treatment response demonstrated a complete metabolic response in the sites of primary disease while also revealing new subcutaneous lesions, which were biopsy-proven recurrent disease. This case illustrates the importance of the different biological behavior of MCL, whereby new sites of metabolically active lesions can represent recurrent disease, even though there is a complete metabolic response at sites of primary disease.
URI: https://ahro.austin.org.au/austinjspui/handle/1/25552
DOI: 10.4103/wjnm.WJNM_65_19
Journal: World Journal of Nuclear Medicine
PubMed URL: 33354186
ISSN: 1450-1147
Type: Journal Article
Subjects: Fluorodeoxyglucose-positron emission tomography/computed tomography
mantle cell lymphoma
recurrent lymphoma
treatment response
Appears in Collections:Journal articles

Show full item record

Page view(s)

38
checked on Nov 29, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.